7 – 10 May 2019 | Lisbon Portugal

At Exhibit Stand #63, we’ll introduce a test service utilizing an innovative in vitro characterization technology that accurately measures the aerosolization, regional deposition, and bioavailability of inhaled drugs under human-realistic breathing profiles.

Proveris Scientific’s European Sales Director, Dr. Deborah Jones, will host an interactive workshop entitled “Control Strategy for pMDI Development and Release Testing: Factors that Impact pMDI Performance” on Wednesday May 8th at the conference.

Please email us at contactus@proveris.com if you would like to arrange a meeting with Ben Okorodudu, VP Sales, or Deborah Jones, Director of Sales during the conference, or to request information.

Respiratory Drug Delivery (RDD®) is a series of academically organized, international symposia focusing on the development and commercialization of pulmonary and nasal pharmaceutical products.